Skip to main content

Table 5 Factors associated with false-negative detection of SLN

From: The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer

Factors

Group 1, n (%)

Group 2, n (%)

P value

Tumor size

 < 4 cm

65 (80.25)

3 (33.33)

0.0019

 ≥ 4 cm

16 (19.75)

6 (66.67)

 

Previous LEEP

 No

39 (48.15)

1 (11.11)

0.0339

 Yes

42 (51.85)

8 (88.89)

 

Parametrium invasion

 No

72 (88.89)

3 (33.33)

< 0.0001

 Yes

9 (11.11)

6 (66.67)

 

Depth of invasion

  < 50%

42(51.85)

0(0)

0.003

  ≥ 50%

39(48.15)

9(100)

 

Vagina extension

 No

73 (90.12)

6 (66.67)

0.0415

 Yes

8 (9.88)

3 (33.33)

 

Resention margin involvement

 NO

80 (98.77)

9 (100)

> 0.999

 Yes

1 (1.23)

0

 

FIGO staging

 IA1

6 (7.41)

0

0.5493

 IA2

6 (7.41)

0

 

 IB1

51 (62.96)

5 (55.56)

 IB2

13 (14.28)

3 (33.33)

 IIA

5 (6.17)

1 (11.11)

  1. SLN sentinel lymph node mapping; LEEP loop electrosurgical excision procedure; FIGO International Federation of Obstetrics and Gynecology; Group 1, no false-negative detection group of sentinel lymph node with bilateral detection of sentinel lymph node; Group 2, false-negative detection group of sentinel lymph node